乳腺癌治疗诱导的衰老:一个概述
Suraj Narayanan Chembukavu1, Andrew J Lindsay1
1Membrane Trafficking and Disease Laboratory, School of Biochemistry & Cell Biology, Biosciences Institute, University College Cork, Cork, T12 YT20, Ireland.
Exploration of targeted anti-tumor therapy
|September 16, 2024
概括
药物治疗诱导的衰老 (TIS) 通过阻止细胞循环,导致乳腺癌的耐药性. 虽然最初具有抗瘤作用,但TIS通过其分泌表型促进长期瘤生长和复发.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 乳腺癌的结果有所改善,但耐药性仍然是一个重大挑战,导致复发和转移.
- 药物治疗诱导的衰老 (TIS) 是获得性抗性的关键机制,其特征是细胞循环停止和与衰老相关的分泌表型 (SASP).
- 各种抗癌疗法可以通过引起基因毒性压力,通路过活化或氧化压力来诱导TIS.
研究的目的:
- 审查TIS在乳腺癌中的特征.
- 详细说明与TIS诱导相关的表型变化.
- 讨论针对衰老细胞的策略,以防止瘤复发.
主要方法:
- 对乳腺癌中药物治疗诱导的衰老研究的文献综述.
- 对伴随TIS的表型变化的分析.
- 探索针对衰老细胞的治疗策略.
主要成果:
- 由抗癌药物诱导的TIS导致细胞循环停止和SASP.
- 虽然TIS可以是短期的抗瘤性,但它通过创造一种亲炎症,免疫抑制的微环境,成为长期的亲瘤性.
- 该SASP促进血管生成和上皮-介质细胞过渡,可能驱动转移.
结论:
- TIS是乳腺癌耐药性的关键机制.
- 该SASP发挥双重作用,最初阻碍,但最终促进瘤的进展和复发.
- 准衰老的癌细胞是一个有前途的治疗途径,可以克服抵抗力并防止复发.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Aging
39
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
39
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


